Real-time fMRI neurofeedback modulates induced hallucinations and underlying brain mechanisms

Hallucinations can occur in the healthy population, are clinically relevant and frequent symptoms in many neuropsychiatric conditions, and have been shown to mark disease progression in patients with neurodegenerative disorders where antipsychotic treatment remains challenging. Here, we combine MR-r...

Full description

Saved in:
Bibliographic Details
Published in:Communications biology Vol. 7; no. 1; pp. 1120 - 15
Main Authors: Dhanis, Herberto, Gninenko, Nicolas, Morgenroth, Elenor, Potheegadoo, Jevita, Rognini, Giulio, Faivre, Nathan, Blanke, Olaf, Van De Ville, Dimitri
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 11-09-2024
Nature Publishing Group
Nature Portfolio
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hallucinations can occur in the healthy population, are clinically relevant and frequent symptoms in many neuropsychiatric conditions, and have been shown to mark disease progression in patients with neurodegenerative disorders where antipsychotic treatment remains challenging. Here, we combine MR-robotics capable of inducing a clinically-relevant hallucination, with real-time fMRI neurofeedback (fMRI-NF) to train healthy individuals to up-regulate a fronto-parietal brain network associated with the robotically-induced hallucination. Over three days, participants learned to modulate occurrences of and transition probabilities to this network, leading to heightened sensitivity to induced hallucinations after training. Moreover, participants who became sensitive and succeeded in fMRI-NF training, showed sustained and specific neural changes after training, characterized by increased hallucination network occurrences during induction and decreased hallucination network occurrences during a matched control condition. These data demonstrate that fMRI-NF modulates specific hallucination network dynamics and highlights the potential of fMRI-NF as a novel antipsychotic treatment in neurodegenerative disorders and schizophrenia. fMRI-neurofeedback targeting a hallucination-related whole-brain network allows individuals to willfully control its temporal properties and modify proneness the hallucination induction, showing promise for investigating future therapies in disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2399-3642
2399-3642
DOI:10.1038/s42003-024-06842-x